Circulating vascular endothelial growth factor (VEGF) is not a prognostic indicator in malignant melanoma

This publication has 17 references indexed in Scilit:

• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996
• Melanoma Cell Lines Express VEGF Receptor KDR and Respond to Exogenously Added VEGF
  Biochemical and Biophysical Research Communications, 1995
• Human Keratinocytes Express the Three Major Splice Forms of Vascular Endothelial Growth Factor
  Journal of Investigative Dermatology, 1995
• Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
• Hematogenous Spread of Malignant Melanoma Cells in Different Stages of Disease
  Journal of Investigative Dermatology, 1993
• The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects
  Melanoma Research, 1993
• Circulating Intercellular Adhesion Molecule 1 as a Marker of Disease Progression in Cutaneous Melanoma
  New England Journal of Medicine, 1992
• Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
  Endocrine Reviews, 1992
• Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.
  Molecular Biology of the Cell, 1992
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
  Proceedings of the National Academy of Sciences, 1989